Private Investment Firm Czura Thornton Today Introduces Clearstone Central Laboratories as the Newest Member of the Czura Thornton Life Science Group

Private Investment Firm Czura Thornton Today Introduces Clearstone Central
Laboratories as the Newest Member of the Czura Thornton Life Science Group

NEW BRUNSWICK, N.J., Nov. 2 /PRNewswire/ -- In a joint statement, Czura
Thornton's founders Tony Czura and Nick Thornton said: "We are delighted to
augment our Life Sciences Group with Clearstone Central Laboratories and the
deep expertise of the people there. We intend to maintain the integrity of the
operational teams and continue to invest in strengthening the company's focus
on exceptional client service. Combined with our renewed focus on the
consistent delivery of high quality service, flexibility and responsiveness
that private ownership allows, we look forward to expanding Clearstone's
market reach."

Clearstone Central Laboratories, formerly MDS Pharma Services' Central Labs
business, is among the largest private Global Central Laboratory companies
solely focused on clinical research and cardiac services. Through a unique
network of wholly owned CAP certified laboratories, Clearstone offers central
laboratory services spanning the clinical development lifecycle. With
strategically placed laboratories in the Americas, Europe and Asia, all are
equivalently equipped and harmonized to provide consistent, dependable results
across programs, study phases and geographies.

In addition, Clearstone leverages information technology tools aligned with
value add project management principles for managing global clinical trials.
Each of its laboratories utilizes the company's centralized APOLLO-CLPM(TM)
(Central Laboratory Protocol Manager) enabling Clearstone project management
teams with real-time visibility to component and test level data. Viq Pervaaz,
Vice President of Global Project Management commented, "We facilitate our
strong project management and data management teams with innovative technology
solutions and an advanced web based protocol management system to meet the
needs of our clients."

About Czura Thornton: Czura Thornton is a private investment group that was
founded by Tony Czura and Nick Thornton in 2003. The group, which owns leading
CRO Chiltern (www.chiltern.com), has interests in the life sciences,
international trade, property and automotive sectors. In particular Messrs
Czura and Thornton have extensive international experience in the laboratory
and CRO sectors. For further information see www.czurathornton.com.

About Clearstone Central Laboratories: Clearstone Central Laboratories offers
clinical laboratory and cardiac services solutions spanning the globe with 600
people and 6 facilities in Paris, Hamburg, Toronto, New Jersey, *Beijing and
Singapore.
For further information see www.clearstonelabs.com.

*The acquisition of the China business is pending subject to receipt of
required Chinese governmental approvals.

SOURCE Clearstone Central Laboratories

Elan Josielewski, Clearstone Central Laboratories, +1-732-951-3250,
Elan.Josielewski@clearstonelabs.com